Artelo Biosciences Inc ARTL:NASDAQ

Last Price$5.12NASDAQ Previous Close - Last Trade as of 4:00PM ET 8/18/22

Today's Change-0.23(4.30%)
Bid (Size)$5.00 (11)
Ask (Size)$5.14 (9)
Day Low / High$4.95 - 5.36
Volume278.8 K

View Pharmaceuticals: Major IndustryPeer Comparison as of 08/18/2022


Artelo Biosciences Inc ( NASDAQ )

Price: $5.12
Change: -0.23 (4.30%)
Volume: 278.8 K
4:00PM ET 8/18/2022

Adial Pharmaceuticals Inc ( NASDAQ )

Price: $0.59
Change: +0.02 (3.58%)
Volume: 868.0 K
4:00PM ET 8/18/2022

Pulmatrix Inc ( NASDAQ )

Price: $4.68
Change: +0.03 (0.65%)
Volume: 17.9 K
3:52PM ET 8/18/2022

Navidea Biopharmaceuticals Inc ( NYSE MKT LLC )

Price: $0.45
Change: -0.08 (14.58%)
Volume: 306.9 K
8:00PM ET 8/18/2022

NovaBay Pharmaceuticals Inc ( NYSE MKT LLC )

Price: $0.26
Change: +0.005 (1.94%)
Volume: 170.0 K
8:00PM ET 8/18/2022

Read more news Recent News

Top Premarket Decliners
8:00AM ET 8/17/2022 MT Newswires

Iterum Therapeutics (ITRM) shares slumped 18% after the company said it will implement a 1-for-15 reverse stock split. Artelo Biosciences (ARTL) shares...

Top Midday Gainers
1:34PM ET 8/16/2022 MT Newswires

GreenBox POS (GBOX) late on Monday reported Q2 sales above market expectations. On Tuesday, GreenBox said it named J. Drew Byelick as its chief financial...

--HC Wainwright Lowers Price Target for Artelo Biosciences to $55 From $60, Maintains Buy Rating
10:18AM ET 8/12/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

Artelo Biosciences Enrolls First Three Cohorts in Cancer-Related Anorexia, Weight-Loss Study
10:38AM ET 7/19/2022 MT Newswires

Artelo Biosciences (ARTL) said Tuesday it has completed enrollment of the first three cohorts in a study evaluating ART27.13 to treat cancer-related...

View all Commentary and Analysis

Artelo Biosciences (ARTL) Investor presentations - Slideshow
11:49AM ET 5/25/2022 Seeking Alpha

Artelo Biosciences Rounding A Corner With Cannabinoid-Based Therapy
9:18PM ET 3/08/2022 Seeking Alpha

The Carnage Under The Surface Of The Stock Market
1:51AM ET 1/25/2022 Seeking Alpha

Company Profile

Business DescriptionArtelo Biosciences, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of therapeutics that target lipid-signaling pathways, including the endocannabinoid system. Its product candidate pipeline includes ART27.13-Synthetic Cannabinoid Agonist, ART26.12-FABP5 inhibitor, and ART12.11-Synthetic CBD Cocrystal. The company was founded by James Manley on May 2, 2011 and is headquartered in Solana Beach, CA. View company web site for more details
Address505 Lomas Santa Fe
Solana Beach, California 92075
Number of Employees2
Recent SEC Filing08/12/20224
President, CEO, CFO, Secretary & TreasurerGregory D. Gorgas
Vice President-Finance & OperationsRandy Schreckhise
Chief Medical OfficerSteven D. Reich
Chief Scientific Officer & Senior Vice PresidentAndy Yates

Company Highlights

Price Open$5.23
Previous Close$5.35
52 Week Range$3.61 - 19.80
Market Capitalization$216.6 M
Shares Outstanding42.3 M
SectorHealth Technology
IndustryPharmaceuticals: Major
Next Earnings AnnouncementN/A

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$0.28
Beta vs. S&P 500N/A
Net Profit MarginN/A
Return on Equity-46.49%

Analyst Ratings as of 07/19/2022

Consensus RecommendationConsensus Icon
Powered by Factset